BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34604082)

  • 1. Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial.
    Song YC; Sun GY; Fang H; Tang Y; Song YW; Hu C; Qi SN; Chen B; Jing H; Tang Y; Jin J; Liu YP; Lu NN; Li YX; Wang SL
    Front Oncol; 2021; 11():738318. PubMed ID: 34604082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
    Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
    Haussmann J; Budach W; Corradini S; Krug D; Jazmati D; Tamaskovics B; Bölke E; Pedotoa A; Kammers K; Matuschek C
    Radiat Oncol; 2023 Nov; 18(1):181. PubMed ID: 37919752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial.
    Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Stenbygaard L; Pedersen AN; Thomsen MS; Yates E; Berg M; Lorenzen EL; Jensen I; Josipovic M; Jensen MB; Overgaard J;
    J Clin Oncol; 2022 Dec; 40(36):4189-4197. PubMed ID: 35930754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial.
    Polgár C; Fodor J; Major T; Németh G; Lövey K; Orosz Z; Sulyok Z; Takácsi-Nagy Z; Kásler M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):694-702. PubMed ID: 17531400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
    Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
    Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
    Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.
    Jacobs DHM; Charaghvandi RK; Horeweg N; Maduro JH; Speijer G; Roeloffzen EMA; Mast M; Bantema-Joppe E; Petoukhova AL; van den Bongard DHJG; Koper P; Crijns APG; Marijnen CAM; Verkooijen HM
    Breast Cancer Res Treat; 2021 Sep; 189(2):387-398. PubMed ID: 34216316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of young age on local control after partial breast irradiation in Japanese patients with early stage breast cancer.
    Sato K; Mizuno Y; Fuchikami H; Kato M; Shimo T; Kubota J; Takeda N; Inoue Y; Seto H; Okawa T
    Breast Cancer; 2017 Jan; 24(1):79-85. PubMed ID: 26832859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study.
    Polgár C; Major T; Takácsi-Nagy Z; Fodor J
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):998-1006. PubMed ID: 33186620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
    Livi L; Meattini I; Marrazzo L; Simontacchi G; Pallotta S; Saieva C; Paiar F; Scotti V; De Luca Cardillo C; Bastiani P; Orzalesi L; Casella D; Sanchez L; Nori J; Fambrini M; Bianchi S
    Eur J Cancer; 2015 Mar; 51(4):451-463. PubMed ID: 25605582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radiation dose to the left anterior descending artery by whole and partial breast irradiation in breast cancer patients.
    Sato K; Mizuno Y; Fuchikami H; Kato M; Shimo T; Kubota J; Takeda N; Inoue Y; Seto H; Okawa T
    J Contemp Brachytherapy; 2015 Feb; 7(1):23-8. PubMed ID: 25829933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.
    Rayan G; Dawson LA; Bezjak A; Lau A; Fyles AW; Yi QL; Merante P; Vallis KA
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):154-61. PubMed ID: 12504048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
    Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
    Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial Breast Irradiation: A Longitudinal Study of Symptoms and Quality of Life.
    Siefert ML; Fennie K; Knobf MT
    Clin J Oncol Nurs; 2018 Dec; 22(6):635-642. PubMed ID: 30452011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol.
    Civil YA; Oei AL; Duvivier KM; Bijker N; Meijnen P; Donkers L; Verheijen S; van Kesteren Z; Palacios MA; Schijf LJ; Barbé E; Konings IRHM; -van der Houven van Oordt CWM; Westhoff PG; Meijer HJM; Diepenhorst GMP; Thijssen V; Mouliere F; Slotman BJ; van der Velde S; van den Bongard HJGD
    BMC Cancer; 2023 May; 23(1):419. PubMed ID: 37161377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.